Profil
Ingrid C.
Choong worked as a Senior Scientist at Sunesis Pharmaceuticals, Inc. from 1999 to 2008.
She then served as an Investor Relations Officer at Eiger BioPharmaceuticals, Inc. In 2008, she returned to Eiger BioPharmaceuticals, Inc. as the SVP-Clinical Development & Head-Investor Relations.
In terms of education, Dr. Choong obtained an undergraduate degree from the California Institute of Technology and a doctorate from the University of California, Berkeley.
Tidigare kända positioner av Ingrid Choong
| Företag | Position | Slut |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Teknisk/Vetenskaplig/F&U Direktör | 2023-09-01 |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Investor Relations Kontakt | 2016-03-29 |
| VIRACTA THERAPEUTICS, INC. | Företagsledare/Principal | 2008-01-01 |
Ingrid Choongs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















